{"id":"haletazole","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"episol","offLabel":[],"synonyms":["halethazole","episol","haletazole","haletazole citrate","haletazole tartrate","haletazole oxalate","haletazole hydrochloride","haletazole HCl"],"timeline":[],"approvals":[],"brandName":"Episol","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine Haletazole as a key that fits into a specific lock in the body. When it binds to that lock, it triggers a series of events that help to treat a particular disease or condition. This is a simplified explanation of how Haletazole works at a molecular level.","oneSentence":"Haletazole works by binding to specific proteins or receptors in the body to produce a therapeutic effect.","technicalDetail":"Haletazole's exact mechanism of action is unknown, but as a small molecule, it is likely to interact with specific biological molecules such as enzymes, receptors, or ion channels to produce its therapeutic effect."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3456","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=haletazole","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T14:57:04.108609","biosimilars":[],"competitors":[],"genericName":"haletazole","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"003904","UNII":"U89MCO87LX","CHEBI":"CHEBI:135524","INN_ID":"1281","UMLSCUI":"C0770998","ChEMBL_ID":"CHEMBL1397608","DRUGBANK_ID":"DB15942","PUBCHEM_CID":"17457","SECONDARY_CAS_RN":"10390-80-4"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Haletazole, also known as Episol, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. Further information on its mechanism of action, safety considerations, and availability is needed. A comprehensive understanding of Haletazole's properties and uses requires additional research.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}